Jefferies Group's position in Astrazeneca plc is currently worth $444 Thousand. That's 0.01% of their equity portfolio (757th largest holding). The first Astrazeneca plc trade was made in Q4 2022. Since then Jefferies Group bought shares three more times and sold shares on five occasions. The investor's estimated purchase price is $454 Thousand, resulting in a loss of 2.3%.
LOS ANGELES , Feb. 20, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against AstraZeneca PLC ("AstraZeneca" or "the Comp...
LOS ANGELES , Jan. 23, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against AstraZeneca PLC ("AstraZeneca" or "the Comp...
Shares of Aptamer Group PLC (AIM:APTA) were up 12% after announcing a new collaboration with AstraZeneca PLC (LSE:AZN) to explore the use of Optimer technolo...
One secret to making money in the markets is to keep holding winners and exit the losers as soon as a red flag appears. Investors need to keep aside biases a...